Canova medication

Immunomodulator from Brazil; contains as fundamental substances: Aconitum napellus, Arsenicum album, Bryonia alba, Thuya occidentalis and Lachesis muta venom

Networked: 3 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Bersani-Amado, Ciomar Aparecida: 2 articles (09/2016 - 12/2010)
2.	Cuman, Roberto Kenji Nakamura: 2 articles (09/2016 - 12/2010)
3.	Ames, Franciele Queiroz: 1 article (09/2016)
4.	Bracht, Lívia: 1 article (09/2016)
5.	Pupulin, Áurea Regina Telles: 1 article (09/2016)
6.	da Rocha, Bruno Ambrósio: 1 article (09/2016)
7.	de Oliveira Dalalio, Márcia Machado: 1 article (09/2016)
8.	de Souza Silva-Comar, Francielli Maria: 1 article (09/2016)
9.	Gomes, Mônica Lúcia: 1 article (12/2010)
10.	Marques-Araujo, Silvana: 1 article (12/2010)

Related Diseases

1.	Infections 12/01/2010 - "The goals of this study were to evaluate the effect of the Canova medication, a homeopathic immune-system modulator, on the evolution of infection induced by the Trypanosoma cruzi Y strain in mice. " 08/01/2005 - "This study investigates the action of Canova medication (CM) on experimental infection by Leishmania (Leishmania) amazonensis, utilizing in vitro and in vivo assays. " 08/01/2005 - "Immunomodulatory effect of Canova medication on experimental Leishmania amazonensis infection."
2.	Body Weight (Weight, Body) 09/01/2016 - "Animals were divided into five groups: non-treated infected animals (I); benznidazole-treated infected animals (Bz; 100 mg/kg body weight, single daily dose by gavage); Canova medication (CM) treated infected animals (CM; 0.2 mL/animal, single daily dose by gavage); benznidazole- and Canova medication-treated infected animals with the above-mentioned dose (Bz+CM); and non-infected animals (C). "

Related Drugs and Biologics

1.	benzonidazole (benznidazole)